A review of clinical trials of anti-VEGF agents for diabetic retinopathy

BP Nicholson, AP Schachat - Graefe's Archive for Clinical and …, 2010 - Springer
Background Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age
population worldwide. Many observational and preclinical studies have implicated vascular …

Screening for diabetic retinopathy

DE Singer, DM Nathan, HA Fogel… - Annals of internal …, 1992 - acpjournals.org
▪ Purpose: To determine the appropriate patients, methods, and timing for screening for
diabetic retinopathy.▪ Data Sources: Relevant articles were identified through prominent …

Risk factors for open-angle glaucoma: the Barbados Eye Study

MC Leske, AMS Connell, SY Wu… - Archives of …, 1995 - jamanetwork.com
Objective: To evaluate risk factors for open-angle glaucoma among black participants in the
Barbados Eye Study. Design: Population-based study of demographic, medical, ocular …

The Barbados Eye Study: prevalence of open angle glaucoma

MC Leske, AMS Connell, AP Schachat… - Archives of …, 1994 - jamanetwork.com
Objective: To describe the design of the Barbados Eye Study and report on the prevalence
of open angle glaucoma (OAG) in a predominantly black study population. Design …

Hypertension, cardiovascular disease, and age-related macular degeneration

L Hyman, AP Schachat, Q He… - Archives of …, 2000 - jamanetwork.com
Objectives To describe a case-control study of risk factors for neovascular and non-
neovascular age-related macular degeneration (AMD) and to present findings on …

Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study

KA Kwiterovich, MG Maguire, RP Murphy, AP Schachat… - Ophthalmology, 1991 - Elsevier
Intravenous fluorescein angiography is a commonly performed and extraordinarily valuable
diagnostic procedure. The frequency of adverse reactions after angiography has varied …

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

KJ Blinder, MS Blumenkranz, NM Bressler… - …, 2003 - europepmc.org
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year
results of a randomized clinical trial--VIP report no. 3. - Abstract - Europe PMC Sign in | Create an …

A review of mortality from choroidal melanoma: II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988

M Diener-West, BS Hawkins, JA Markowitz… - Archives of …, 1992 - jamanetwork.com
• With the use of data published during the period from 1966 through 1988, a pooled
analysis (meta-analysis) of 5-year mortality rates among patients who had an eye …

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy …

LM Jampol, CS Moy, TG Murray, SM Reynolds… - Ophthalmology, 2002 - Elsevier
OBJECTIVE: To describe the frequency and predictors of local treatment failure and
enucleation after iodine 125 (I125) brachytherapy in patients with choroidal melanoma …

Neovascular age-related macular degeneration

J Shao, MM Choudhary, AP Schachat - Retinal Pharmacotherapeutics, 2016 - karger.com
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in
individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of …